Piperonyl and Sulindac share 11 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.355 means 35% of the combined target set is bound by both compounds. The IDF-weighted score of 0.276 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Piperonyl and Sulindac have in common?
Piperonyl and Sulindac share 11 molecular targets with a Jaccard similarity of 35%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Piperonyl and Sulindac be combined?
Piperonyl and Sulindac share 11 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Piperonyl or Sulindac?
Both Piperonyl and Sulindac have substantial PubMed research. View their individual profiles for full evidence scores.